This announcement, relayed by the Union of Industries for the Valorization of Hemp Extracts (UIVEC), follows several weeks of positive signals from the French government and could finally unlock a process that had been at a standstill since the end of the national pilot program on medical cannabis.

On June 30, Laurent Panifous, Minister Delegate for Relations with Parliament, confirmed to the Senate that the decree had received the approval of the Ministry of Economy, Finance and Industrial and Digital Sovereignty. According to the government, the text was submitted to the Council of State on July 2nd. The legal review is expected to take place after the summer recess, with publication planned for the start of the next parliamentary session.

This confirmation follows a question from Senator Marion Canales, who highlighted the difficult situation faced by patients since 2024. While patients already enrolled in the French pilot program continue to receive treatment, no new patients have been able to join the program, as the regulatory framework is not yet finalized. For thousands of patients suffering from treatment-resistant conditions, access to medical cannabis has therefore remained effectively frozen.